3) Dynavax Technologies Corporation (DVAX) – Two top hedge funds that own more than 8% of this biotech stock. The two funds, Orbimed Advisors and RA Capital Management, are both biotech focused hedge funds run by MDs and PhDs. They paid an average cost of $3.10 for Dynavax. That means if you buy Dynavax today you are buying it at 61% discount to what these top biotech hedge funds paid for their shares.

http://us.rd.yahoo.com/finance/external/forbes/SIG=13gpbh38r/*http://www.forbes.com/sites/greatspeculations/2013/10/17/four-beaten-down-stocks-that-billionaires-are-buying/?partner=yahootix